As a result, laboratories frequently incorporate combination products into comparative studies, analytical reviews, and broader research initiatives involving formulation assessment
The SURPASS clinical trial program has assessed varying doses of tirzepatide across five different trials, each demonstrating significant A1c reduction and low rates of hypoglycemia compared to placebo, semaglutide (GLP-1R agonist), dulaglutide (GLP-1R agonist), and insulin (lispro, glargine, degludec)
Because tirzepatide affects blood sugar, it is important for patients taking other diabetes medications to be closely monitored to avoid hypoglycemia (low blood sugar)
Your journey will include detailed body composition reports powered by the Styku Body Scanner that will help us to track your progress properly
Mayo Clinic Proceedings, 92 (1), 114128
This hormone helps to regulate your blood sugar levels, and also sends signals to receptors in your brain that manage your appetite, allowing you to feel fuller for longer